Full Author : ['Petrie, Mark C', 'Verma, Subodh', 'Docherty, Kieran F', 'Inzucchi, Silvio E', 'Anand, Inder', 'Belohlavek, Jan', 'Bohm, Michael', 'Chiang, Chern-En', 'Chopra, Vijay K', 'de Boer, Rudolf A', 'Desai, Akshay S', 'Diez, Mirta', 'Drozdz, Jaroslaw', 'Dukat, Andre', 'Ge, Junbo', 'Howlett, Jonathan', 'Katova, Tzvetana', 'Kitakaze, Masafumi', 'Ljungman, Charlotta E A', 'Merkely, Bela', 'Nicolau, Jose C', "O'Meara, Eileen", 'Vinh, Pham Nguyen', 'Schou, Morten', 'Tereshchenko, Sergey', 'Kober, Lars', 'Kosiborod, Mikhail N', 'Langkilde, Anna Maria', 'Martinez, Felipe A', 'Ponikowski, Piotr', 'Sabatine, Marc S', 'Sjostrand, Mikaela', 'Solomon, Scott D', 'Johanson, Per', 'Greasley, Peter J', 'Boulton, David', 'Bengtsson, Olof', 'Jhund, Pardeep S', 'McMurray, John J V']
Journal Title : JAMA
Chapter : Section1, Section3
Journal Year : 2020
Cited by : 364.0
IMPORTANCE: Additional treatments are needed for heart failure with reduced ejection fraction (HFrEF). Sodium-glucose cotransporter 2 (SGLT2) inhibitors may be an effective treatment for patients with HFrEF, even those without diabetes. OBJECTIVE: To eval.....
Read More
